nodes	percent_of_prediction	percent_of_DWPC	metapath
Acamprosate—GRIN1—Spinal Cord Injury—CCL2—asthma	0.000322	0.00139	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—EDNRB—asthma	0.00032	0.00139	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—NPS—asthma	0.000317	0.00137	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—TAC1—asthma	0.000317	0.00137	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—NPY—asthma	0.000315	0.00136	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—CHAT—asthma	0.000312	0.00135	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—CXCR3—asthma	0.000311	0.00135	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—TAC1—asthma	0.00031	0.00134	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PTGDR2—asthma	0.000309	0.00134	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PMCH—asthma	0.000309	0.00134	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—HRH4—asthma	0.000309	0.00134	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—NPSR1—asthma	0.000309	0.00134	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—CHAT—asthma	0.000307	0.00133	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—GATA3—asthma	0.000304	0.00132	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—AGTR2—asthma	0.000304	0.00131	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CSF2RB—asthma	0.000302	0.00131	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—NTRK1—asthma	0.0003	0.0013	CbGpPWpGaD
Acamprosate—GRIN1—Neuronal System—ADCY2—asthma	0.000299	0.00129	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—TACR2—asthma	0.000296	0.00128	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CCR8—asthma	0.000296	0.00128	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—IL5—asthma	0.000295	0.00128	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—IL1RN—asthma	0.000295	0.00127	CbGpPWpGaD
Acamprosate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY2—asthma	0.000294	0.00127	CbGpPWpGaD
Acamprosate—GRIN2B—Neuronal System—ADCY2—asthma	0.000291	0.00126	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—EDNRB—asthma	0.000291	0.00126	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CCL17—asthma	0.00029	0.00126	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—RHOA—asthma	0.00029	0.00125	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—NPS—asthma	0.000288	0.00125	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—TAC1—asthma	0.000288	0.00125	CbGpPWpGaD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—ADCY2—asthma	0.000286	0.00124	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—ALDH2—asthma	0.000285	0.00123	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—BDKRB2—asthma	0.000284	0.00123	CbGpPWpGaD
Acamprosate—SLC36A1—SLC-mediated transmembrane transport—ALB—asthma	0.000284	0.00123	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—CXCR3—asthma	0.000282	0.00122	CbGpPWpGaD
Acamprosate—GRIN2A—Alzheimers Disease—TNF—asthma	0.00028	0.00121	CbGpPWpGaD
Acamprosate—GRIN1—EPH-Ephrin signaling—MMP9—asthma	0.000276	0.0012	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—ADCY2—asthma	0.000275	0.00119	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—BDNF—asthma	0.000274	0.00119	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—IL3—asthma	0.000274	0.00119	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—IFNG—asthma	0.000274	0.00118	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—ESR2—asthma	0.000273	0.00118	CbGpPWpGaD
Acamprosate—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—asthma	0.00027	0.00117	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—POMC—asthma	0.00027	0.00117	CbGpPWpGaD
Acamprosate—GRIN2B—EPH-Ephrin signaling—MMP9—asthma	0.000269	0.00117	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—CHAT—asthma	0.000268	0.00116	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—IL5—asthma	0.000268	0.00116	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—CCL2—asthma	0.000264	0.00114	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—PTGS2—asthma	0.000262	0.00114	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PDE4A—asthma	0.000259	0.00112	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—KIF3A—asthma	0.000259	0.00112	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—KNG1—asthma	0.000259	0.00112	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—BDKRB2—asthma	0.000258	0.00112	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—AGTR1—asthma	0.000257	0.00111	CbGpPWpGaD
Acamprosate—GABRB3—Transmission across Chemical Synapses—ADCY2—asthma	0.000257	0.00111	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—IL6R—asthma	0.000257	0.00111	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—CARM1—asthma	0.000255	0.0011	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—ALDH2—asthma	0.000255	0.0011	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—CXCL8—asthma	0.000255	0.0011	CbGpPWpGaD
Acamprosate—GABRG2—Transmission across Chemical Synapses—ADCY2—asthma	0.000252	0.00109	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—CXCL10—asthma	0.000251	0.00109	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—ALDH2—asthma	0.00025	0.00108	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—ADCY2—asthma	0.00025	0.00108	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—IL3—asthma	0.000249	0.00108	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—CARM1—asthma	0.000248	0.00108	CbGpPWpGaD
Acamprosate—GRIN1—EPH-Ephrin signaling—VEGFA—asthma	0.000248	0.00107	CbGpPWpGaD
Acamprosate—GRIN1—Alzheimers Disease—TNF—asthma	0.000244	0.00106	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—IL1B—asthma	0.000244	0.00106	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—ADRB2—asthma	0.000244	0.00106	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—IL2—asthma	0.000243	0.00105	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CYSLTR1—asthma	0.000242	0.00105	CbGpPWpGaD
Acamprosate—GRIN2B—EPH-Ephrin signaling—VEGFA—asthma	0.000242	0.00105	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—PPP2CA—asthma	0.000241	0.00104	CbGpPWpGaD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—HMOX1—asthma	0.00024	0.00104	CbGpPWpGaD
Acamprosate—GRIN2B—Alzheimers Disease—TNF—asthma	0.000238	0.00103	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—KNG1—asthma	0.000235	0.00102	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CCL11—asthma	0.000234	0.00101	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—C5AR1—asthma	0.000234	0.00101	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—VIP—asthma	0.000234	0.00101	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CMA1—asthma	0.000234	0.00101	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—UTS2—asthma	0.000234	0.00101	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—AGTR1—asthma	0.000234	0.00101	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—SLC26A4—asthma	0.000232	0.00101	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—ITPR1—asthma	0.000231	0.000999	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—MMP9—asthma	0.00023	0.000996	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—CXCL10—asthma	0.000228	0.000988	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—SLC26A4—asthma	0.000228	0.000987	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CCR4—asthma	0.000224	0.000971	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—ADRB2—asthma	0.000222	0.000959	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—BDNF—asthma	0.000221	0.000956	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—ADCY2—asthma	0.000221	0.000955	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—STAT6—asthma	0.00022	0.000952	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—ALDH2—asthma	0.000219	0.000946	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—EDN1—asthma	0.000218	0.000943	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—CCL5—asthma	0.000216	0.000936	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IL2RB—asthma	0.000216	0.000935	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PDE4D—asthma	0.000214	0.000926	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—CSF2—asthma	0.000213	0.000922	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—SLC30A8—asthma	0.000212	0.000919	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—ATP4A—asthma	0.000212	0.000919	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—IL10—asthma	0.000211	0.000912	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—ITPR1—asthma	0.00021	0.000907	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—ATP4A—asthma	0.000209	0.000903	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—SLC30A8—asthma	0.000209	0.000903	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—C5—asthma	0.000209	0.000903	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PDE4B—asthma	0.000209	0.000903	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—TACR1—asthma	0.000209	0.000903	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—CXCL8—asthma	0.000208	0.000902	CbGpPWpGaD
Acamprosate—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—asthma	0.000208	0.000899	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—CXCL8—asthma	0.000204	0.000881	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—SLC26A4—asthma	0.000199	0.000863	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—EDN1—asthma	0.000198	0.000857	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—ADCY2—asthma	0.000197	0.000852	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—CCL5—asthma	0.000196	0.00085	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—PLA2G4A—asthma	0.000196	0.000847	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—IL1B—asthma	0.000195	0.000845	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—NR3C1—asthma	0.000195	0.000844	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—CCR5—asthma	0.000195	0.000843	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—CSF2—asthma	0.000193	0.000837	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—ADCY2—asthma	0.000193	0.000837	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—IL2RA—asthma	0.000192	0.000831	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CCR3—asthma	0.000191	0.000826	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—C3—asthma	0.00019	0.000824	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—TGFB1—asthma	0.00019	0.000821	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—EGFR—asthma	0.000186	0.000805	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—NPY—asthma	0.000186	0.000805	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—SLC30A8—asthma	0.000182	0.000789	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—ATP4A—asthma	0.000182	0.000789	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—PPP2CA—asthma	0.00018	0.00078	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—AGTR2—asthma	0.000179	0.000776	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—TNF—asthma	0.000177	0.000767	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—CCR5—asthma	0.000177	0.000766	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—STAT3—asthma	0.000175	0.000755	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—IL2RA—asthma	0.000174	0.000755	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—C3—asthma	0.000173	0.000748	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—EDNRB—asthma	0.000172	0.000743	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—STAT3—asthma	0.00017	0.000736	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—TAC1—asthma	0.00017	0.000736	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—NPS—asthma	0.00017	0.000736	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—ADCY2—asthma	0.000169	0.000732	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CXCR3—asthma	0.000167	0.000722	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—VEGFA—asthma	0.000165	0.000716	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CYBA—asthma	0.000162	0.000699	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PARP1—asthma	0.000158	0.000684	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IL5—asthma	0.000158	0.000684	CbGpPWpGaD
Acamprosate—Angioedema—Methylprednisolone—asthma	0.000156	0.000203	CcSEcCtD
Acamprosate—Haemorrhage—Prednisone—asthma	0.000155	0.000202	CcSEcCtD
Acamprosate—Myalgia—Hydrocortisone—asthma	0.000155	0.000201	CcSEcCtD
Acamprosate—Hallucination—Prednisone—asthma	0.000154	0.000201	CcSEcCtD
Acamprosate—Malaise—Triamcinolone—asthma	0.000154	0.000201	CcSEcCtD
Acamprosate—Anxiety—Hydrocortisone—asthma	0.000154	0.0002	CcSEcCtD
Acamprosate—Malaise—Methylprednisolone—asthma	0.000154	0.0002	CcSEcCtD
Acamprosate—Vertigo—Triamcinolone—asthma	0.000154	0.0002	CcSEcCtD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—asthma	0.000154	0.0002	CcSEcCtD
Acamprosate—Syncope—Triamcinolone—asthma	0.000153	0.000199	CcSEcCtD
Acamprosate—Vertigo—Methylprednisolone—asthma	0.000153	0.000199	CcSEcCtD
Acamprosate—Syncope—Methylprednisolone—asthma	0.000153	0.000199	CcSEcCtD
Acamprosate—Discomfort—Hydrocortisone—asthma	0.000153	0.000199	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—BDKRB2—asthma	0.000153	0.00066	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—POMC—asthma	0.000152	0.000659	CbGpPWpGaD
Acamprosate—Nausea—Budesonide—asthma	0.000152	0.000198	CcSEcCtD
Acamprosate—Anaphylactic shock—Prednisolone—asthma	0.000152	0.000197	CcSEcCtD
Acamprosate—Loss of consciousness—Triamcinolone—asthma	0.00015	0.000195	CcSEcCtD
Acamprosate—Loss of consciousness—Methylprednisolone—asthma	0.00015	0.000195	CcSEcCtD
Acamprosate—Shock—Prednisolone—asthma	0.000149	0.000194	CcSEcCtD
Acamprosate—Cough—Triamcinolone—asthma	0.000149	0.000194	CcSEcCtD
Acamprosate—Anaphylactic shock—Hydrocortisone—asthma	0.000148	0.000193	CcSEcCtD
Acamprosate—Convulsion—Triamcinolone—asthma	0.000148	0.000193	CcSEcCtD
Acamprosate—Tachycardia—Prednisolone—asthma	0.000148	0.000193	CcSEcCtD
Acamprosate—Convulsion—Methylprednisolone—asthma	0.000148	0.000192	CcSEcCtD
Acamprosate—Hypertension—Triamcinolone—asthma	0.000148	0.000192	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—ADCY2—asthma	0.000148	0.000639	CbGpPWpGaD
Acamprosate—Hypertension—Methylprednisolone—asthma	0.000147	0.000192	CcSEcCtD
Acamprosate—Infection—Hydrocortisone—asthma	0.000147	0.000192	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—IL3—asthma	0.000147	0.000637	CbGpPWpGaD
Acamprosate—Hyperhidrosis—Prednisolone—asthma	0.000147	0.000191	CcSEcCtD
Acamprosate—Shock—Hydrocortisone—asthma	0.000146	0.00019	CcSEcCtD
Acamprosate—Myalgia—Triamcinolone—asthma	0.000146	0.000189	CcSEcCtD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—IL6R—asthma	0.000145	0.000629	CbGpPWpGaD
Acamprosate—Arthralgia—Methylprednisolone—asthma	0.000145	0.000189	CcSEcCtD
Acamprosate—Myalgia—Methylprednisolone—asthma	0.000145	0.000189	CcSEcCtD
Acamprosate—Anxiety—Methylprednisolone—asthma	0.000145	0.000188	CcSEcCtD
Acamprosate—Tachycardia—Hydrocortisone—asthma	0.000145	0.000188	CcSEcCtD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—asthma	0.000144	0.000188	CcSEcCtD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—ALB—asthma	0.000144	0.000624	CbGpPWpGaD
Acamprosate—Skin disorder—Hydrocortisone—asthma	0.000144	0.000187	CcSEcCtD
Acamprosate—Ill-defined disorder—Betamethasone—asthma	0.000144	0.000187	CcSEcCtD
Acamprosate—Ill-defined disorder—Dexamethasone—asthma	0.000144	0.000187	CcSEcCtD
Acamprosate—Discomfort—Triamcinolone—asthma	0.000144	0.000187	CcSEcCtD
Acamprosate—Discomfort—Methylprednisolone—asthma	0.000144	0.000187	CcSEcCtD
Acamprosate—Hyperhidrosis—Hydrocortisone—asthma	0.000143	0.000186	CcSEcCtD
Acamprosate—GRIN1—Axon guidance—IL6R—asthma	0.000143	0.000619	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—IL6—asthma	0.000143	0.000619	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—CARM1—asthma	0.000143	0.000618	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—SMAD3—asthma	0.000143	0.000617	CbGpPWpGaD
Acamprosate—Dry mouth—Triamcinolone—asthma	0.000142	0.000185	CcSEcCtD
Acamprosate—Angioedema—Dexamethasone—asthma	0.000142	0.000184	CcSEcCtD
Acamprosate—Angioedema—Betamethasone—asthma	0.000142	0.000184	CcSEcCtD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—TNF—asthma	0.000142	0.000613	CbGpPWpGaD
Acamprosate—Anorexia—Hydrocortisone—asthma	0.000141	0.000184	CcSEcCtD
Acamprosate—Confusional state—Methylprednisolone—asthma	0.00014	0.000183	CcSEcCtD
Acamprosate—Immune system disorder—Prednisone—asthma	0.00014	0.000182	CcSEcCtD
Acamprosate—GABRG2—Transmembrane transport of small molecules—CARM1—asthma	0.00014	0.000607	CbGpPWpGaD
Acamprosate—Malaise—Dexamethasone—asthma	0.00014	0.000182	CcSEcCtD
Acamprosate—Malaise—Betamethasone—asthma	0.00014	0.000182	CcSEcCtD
Acamprosate—Anaphylactic shock—Triamcinolone—asthma	0.00014	0.000182	CcSEcCtD
Acamprosate—GRIN2B—Axon guidance—IL6R—asthma	0.000139	0.000604	CbGpPWpGaD
Acamprosate—Vertigo—Dexamethasone—asthma	0.000139	0.000181	CcSEcCtD
Acamprosate—Vertigo—Betamethasone—asthma	0.000139	0.000181	CcSEcCtD
Acamprosate—Anaphylactic shock—Methylprednisolone—asthma	0.000139	0.000181	CcSEcCtD
Acamprosate—Syncope—Betamethasone—asthma	0.000139	0.000181	CcSEcCtD
Acamprosate—Syncope—Dexamethasone—asthma	0.000139	0.000181	CcSEcCtD
Acamprosate—GRIN2B—Developmental Biology—SMAD3—asthma	0.000139	0.000601	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—KNG1—asthma	0.000139	0.000601	CbGpPWpGaD
Acamprosate—Infection—Triamcinolone—asthma	0.000139	0.00018	CcSEcCtD
Acamprosate—Hypotension—Hydrocortisone—asthma	0.000139	0.00018	CcSEcCtD
Acamprosate—Infection—Methylprednisolone—asthma	0.000138	0.00018	CcSEcCtD
Acamprosate—GRM5—Signaling by GPCR—POMC—asthma	0.000138	0.000599	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—AGTR1—asthma	0.000138	0.000597	CbGpPWpGaD
Acamprosate—Shock—Triamcinolone—asthma	0.000137	0.000179	CcSEcCtD
Acamprosate—Insomnia—Prednisolone—asthma	0.000137	0.000179	CcSEcCtD
Acamprosate—Alopecia—Prednisone—asthma	0.000137	0.000178	CcSEcCtD
Acamprosate—Shock—Methylprednisolone—asthma	0.000137	0.000178	CcSEcCtD
Acamprosate—Loss of consciousness—Dexamethasone—asthma	0.000136	0.000177	CcSEcCtD
Acamprosate—Loss of consciousness—Betamethasone—asthma	0.000136	0.000177	CcSEcCtD
Acamprosate—Paraesthesia—Prednisolone—asthma	0.000136	0.000177	CcSEcCtD
Acamprosate—Tachycardia—Triamcinolone—asthma	0.000136	0.000177	CcSEcCtD
Acamprosate—Mental disorder—Prednisone—asthma	0.000136	0.000177	CcSEcCtD
Acamprosate—Tachycardia—Methylprednisolone—asthma	0.000136	0.000177	CcSEcCtD
Acamprosate—GRM5—Signaling by GPCR—CCL2—asthma	0.000135	0.000586	CbGpPWpGaD
Acamprosate—Skin disorder—Methylprednisolone—asthma	0.000135	0.000176	CcSEcCtD
Acamprosate—Malnutrition—Prednisone—asthma	0.000135	0.000176	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Hydrocortisone—asthma	0.000135	0.000176	CcSEcCtD
Acamprosate—Hyperhidrosis—Triamcinolone—asthma	0.000135	0.000175	CcSEcCtD
Acamprosate—GRM5—Signaling by GPCR—IL6R—asthma	0.000135	0.000584	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CXCL10—asthma	0.000135	0.000583	CbGpPWpGaD
Acamprosate—Hyperhidrosis—Methylprednisolone—asthma	0.000135	0.000175	CcSEcCtD
Acamprosate—Convulsion—Betamethasone—asthma	0.000134	0.000175	CcSEcCtD
Acamprosate—Convulsion—Dexamethasone—asthma	0.000134	0.000175	CcSEcCtD
Acamprosate—GRM5—GPCR downstream signaling—RHOA—asthma	0.000134	0.000581	CbGpPWpGaD
Acamprosate—Insomnia—Hydrocortisone—asthma	0.000134	0.000174	CcSEcCtD
Acamprosate—Hypertension—Dexamethasone—asthma	0.000134	0.000174	CcSEcCtD
Acamprosate—Hypertension—Betamethasone—asthma	0.000134	0.000174	CcSEcCtD
Acamprosate—Paraesthesia—Hydrocortisone—asthma	0.000133	0.000173	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—NTRK1—asthma	0.000132	0.000572	CbGpPWpGaD
Acamprosate—Myalgia—Dexamethasone—asthma	0.000132	0.000172	CcSEcCtD
Acamprosate—Myalgia—Betamethasone—asthma	0.000132	0.000172	CcSEcCtD
Acamprosate—Anxiety—Dexamethasone—asthma	0.000132	0.000171	CcSEcCtD
Acamprosate—Anxiety—Betamethasone—asthma	0.000132	0.000171	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—ADRB2—asthma	0.000131	0.000566	CbGpPWpGaD
Acamprosate—Discomfort—Dexamethasone—asthma	0.000131	0.00017	CcSEcCtD
Acamprosate—Discomfort—Betamethasone—asthma	0.000131	0.00017	CcSEcCtD
Acamprosate—Dyspepsia—Hydrocortisone—asthma	0.00013	0.00017	CcSEcCtD
Acamprosate—Hypotension—Methylprednisolone—asthma	0.00013	0.000169	CcSEcCtD
Acamprosate—Pain—Prednisolone—asthma	0.00013	0.000169	CcSEcCtD
Acamprosate—GRIN1—Axon guidance—RHOA—asthma	0.000129	0.000559	CbGpPWpGaD
Acamprosate—Decreased appetite—Hydrocortisone—asthma	0.000129	0.000168	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Hydrocortisone—asthma	0.000128	0.000166	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Triamcinolone—asthma	0.000127	0.000165	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Methylprednisolone—asthma	0.000127	0.000165	CcSEcCtD
Acamprosate—Pain—Hydrocortisone—asthma	0.000127	0.000165	CcSEcCtD
Acamprosate—Anaphylactic shock—Dexamethasone—asthma	0.000127	0.000165	CcSEcCtD
Acamprosate—Anaphylactic shock—Betamethasone—asthma	0.000127	0.000165	CcSEcCtD
Acamprosate—Insomnia—Triamcinolone—asthma	0.000126	0.000164	CcSEcCtD
Acamprosate—GRIN2B—Axon guidance—RHOA—asthma	0.000126	0.000545	CbGpPWpGaD
Acamprosate—Insomnia—Methylprednisolone—asthma	0.000126	0.000164	CcSEcCtD
Acamprosate—Infection—Betamethasone—asthma	0.000126	0.000164	CcSEcCtD
Acamprosate—Infection—Dexamethasone—asthma	0.000126	0.000164	CcSEcCtD
Acamprosate—Ill-defined disorder—Prednisone—asthma	0.000125	0.000163	CcSEcCtD
Acamprosate—Paraesthesia—Triamcinolone—asthma	0.000125	0.000163	CcSEcCtD
Acamprosate—Feeling abnormal—Prednisolone—asthma	0.000125	0.000163	CcSEcCtD
Acamprosate—Paraesthesia—Methylprednisolone—asthma	0.000125	0.000163	CcSEcCtD
Acamprosate—Anaemia—Prednisone—asthma	0.000125	0.000162	CcSEcCtD
Acamprosate—Shock—Dexamethasone—asthma	0.000125	0.000162	CcSEcCtD
Acamprosate—Shock—Betamethasone—asthma	0.000125	0.000162	CcSEcCtD
Acamprosate—Dyspnoea—Triamcinolone—asthma	0.000124	0.000162	CcSEcCtD
Acamprosate—Agitation—Prednisone—asthma	0.000124	0.000162	CcSEcCtD
Acamprosate—Thrombocytopenia—Betamethasone—asthma	0.000124	0.000161	CcSEcCtD
Acamprosate—Thrombocytopenia—Dexamethasone—asthma	0.000124	0.000161	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—ITPR1—asthma	0.000124	0.000536	CbGpPWpGaD
Acamprosate—Tachycardia—Betamethasone—asthma	0.000124	0.000161	CcSEcCtD
Acamprosate—Tachycardia—Dexamethasone—asthma	0.000124	0.000161	CcSEcCtD
Acamprosate—Angioedema—Prednisone—asthma	0.000123	0.000161	CcSEcCtD
Acamprosate—Dyspepsia—Triamcinolone—asthma	0.000123	0.00016	CcSEcCtD
Acamprosate—Dyspepsia—Methylprednisolone—asthma	0.000123	0.000159	CcSEcCtD
Acamprosate—GABRA1—Transmembrane transport of small molecules—CARM1—asthma	0.000123	0.00053	CbGpPWpGaD
Acamprosate—Hyperhidrosis—Betamethasone—asthma	0.000122	0.000159	CcSEcCtD
Acamprosate—Hyperhidrosis—Dexamethasone—asthma	0.000122	0.000159	CcSEcCtD
Acamprosate—Feeling abnormal—Hydrocortisone—asthma	0.000122	0.000159	CcSEcCtD
Acamprosate—GRM5—Signaling by GPCR—RHOA—asthma	0.000122	0.000527	CbGpPWpGaD
Acamprosate—Malaise—Prednisone—asthma	0.000122	0.000158	CcSEcCtD
Acamprosate—GRIN1—Developmental Biology—LEP—asthma	0.000122	0.000527	CbGpPWpGaD
Acamprosate—Vertigo—Prednisone—asthma	0.000121	0.000158	CcSEcCtD
Acamprosate—Gastrointestinal pain—Hydrocortisone—asthma	0.000121	0.000158	CcSEcCtD
Acamprosate—Syncope—Prednisone—asthma	0.000121	0.000158	CcSEcCtD
Acamprosate—Anorexia—Dexamethasone—asthma	0.000121	0.000157	CcSEcCtD
Acamprosate—Anorexia—Betamethasone—asthma	0.000121	0.000157	CcSEcCtD
Acamprosate—Urticaria—Prednisolone—asthma	0.000121	0.000157	CcSEcCtD
Acamprosate—Pain—Triamcinolone—asthma	0.000119	0.000155	CcSEcCtD
Acamprosate—Loss of consciousness—Prednisone—asthma	0.000119	0.000154	CcSEcCtD
Acamprosate—GRIN2B—Developmental Biology—LEP—asthma	0.000119	0.000514	CbGpPWpGaD
Acamprosate—Hypotension—Dexamethasone—asthma	0.000118	0.000154	CcSEcCtD
Acamprosate—Hypotension—Betamethasone—asthma	0.000118	0.000154	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—CD86—asthma	0.000118	0.00051	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—CXCL8—asthma	0.000118	0.00051	CbGpPWpGaD
Acamprosate—Urticaria—Hydrocortisone—asthma	0.000118	0.000153	CcSEcCtD
Acamprosate—Abdominal pain—Hydrocortisone—asthma	0.000117	0.000152	CcSEcCtD
Acamprosate—Body temperature increased—Hydrocortisone—asthma	0.000117	0.000152	CcSEcCtD
Acamprosate—Convulsion—Prednisone—asthma	0.000117	0.000152	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—EDN1—asthma	0.000117	0.000506	CbGpPWpGaD
Acamprosate—Hypertension—Prednisone—asthma	0.000117	0.000152	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—CCL5—asthma	0.000116	0.000502	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PLA2G4A—asthma	0.000116	0.0005	CbGpPWpGaD
Acamprosate—Musculoskeletal discomfort—Betamethasone—asthma	0.000115	0.00015	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Dexamethasone—asthma	0.000115	0.00015	CcSEcCtD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—CXCL8—asthma	0.000115	0.000499	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—STAT3—asthma	0.000115	0.000498	CbGpPWpGaD
Acamprosate—Arthralgia—Prednisone—asthma	0.000115	0.00015	CcSEcCtD
Acamprosate—Myalgia—Prednisone—asthma	0.000115	0.00015	CcSEcCtD
Acamprosate—Feeling abnormal—Triamcinolone—asthma	0.000115	0.00015	CcSEcCtD
Acamprosate—Feeling abnormal—Methylprednisolone—asthma	0.000115	0.000149	CcSEcCtD
Acamprosate—Anxiety—Prednisone—asthma	0.000115	0.000149	CcSEcCtD
Acamprosate—Insomnia—Dexamethasone—asthma	0.000115	0.000149	CcSEcCtD
Acamprosate—Insomnia—Betamethasone—asthma	0.000115	0.000149	CcSEcCtD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—IL6—asthma	0.000114	0.000495	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CSF2—asthma	0.000114	0.000495	CbGpPWpGaD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—asthma	0.000114	0.000149	CcSEcCtD
Acamprosate—Gastrointestinal pain—Methylprednisolone—asthma	0.000114	0.000148	CcSEcCtD
Acamprosate—Paraesthesia—Dexamethasone—asthma	0.000114	0.000148	CcSEcCtD
Acamprosate—Paraesthesia—Betamethasone—asthma	0.000114	0.000148	CcSEcCtD
Acamprosate—Discomfort—Prednisone—asthma	0.000114	0.000148	CcSEcCtD
Acamprosate—GRM5—GPCR downstream signaling—IL2—asthma	0.000113	0.000487	CbGpPWpGaD
Acamprosate—Hypersensitivity—Prednisolone—asthma	0.000112	0.000145	CcSEcCtD
Acamprosate—Dyspepsia—Dexamethasone—asthma	0.000111	0.000145	CcSEcCtD
Acamprosate—Dyspepsia—Betamethasone—asthma	0.000111	0.000145	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—SMAD3—asthma	0.000111	0.000482	CbGpPWpGaD
Acamprosate—Urticaria—Triamcinolone—asthma	0.000111	0.000144	CcSEcCtD
Acamprosate—Urticaria—Methylprednisolone—asthma	0.000111	0.000144	CcSEcCtD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—IL1B—asthma	0.000111	0.000479	CbGpPWpGaD
Acamprosate—Body temperature increased—Triamcinolone—asthma	0.00011	0.000144	CcSEcCtD
Acamprosate—Anaphylactic shock—Prednisone—asthma	0.00011	0.000143	CcSEcCtD
Acamprosate—Abdominal pain—Methylprednisolone—asthma	0.00011	0.000143	CcSEcCtD
Acamprosate—Decreased appetite—Dexamethasone—asthma	0.00011	0.000143	CcSEcCtD
Acamprosate—Decreased appetite—Betamethasone—asthma	0.00011	0.000143	CcSEcCtD
Acamprosate—Infection—Prednisone—asthma	0.00011	0.000143	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Betamethasone—asthma	0.000109	0.000142	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Dexamethasone—asthma	0.000109	0.000142	CcSEcCtD
Acamprosate—Hypersensitivity—Hydrocortisone—asthma	0.000109	0.000142	CcSEcCtD
Acamprosate—Shock—Prednisone—asthma	0.000109	0.000141	CcSEcCtD
Acamprosate—Pain—Betamethasone—asthma	0.000108	0.000141	CcSEcCtD
Acamprosate—Pain—Dexamethasone—asthma	0.000108	0.000141	CcSEcCtD
Acamprosate—Tachycardia—Prednisone—asthma	0.000108	0.00014	CcSEcCtD
Acamprosate—Skin disorder—Prednisone—asthma	0.000107	0.000139	CcSEcCtD
Acamprosate—GRM5—Signaling by GPCR—CXCL8—asthma	0.000107	0.000463	CbGpPWpGaD
Acamprosate—Hyperhidrosis—Prednisone—asthma	0.000107	0.000139	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—PPP2CA—asthma	0.000106	0.000461	CbGpPWpGaD
Acamprosate—Asthenia—Hydrocortisone—asthma	0.000106	0.000138	CcSEcCtD
Acamprosate—GABRB3—Transmembrane transport of small molecules—ADCY2—asthma	0.000106	0.000458	CbGpPWpGaD
Acamprosate—Anorexia—Prednisone—asthma	0.000105	0.000137	CcSEcCtD
Acamprosate—Pruritus—Hydrocortisone—asthma	0.000105	0.000136	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—CCR5—asthma	0.000105	0.000452	CbGpPWpGaD
Acamprosate—Feeling abnormal—Dexamethasone—asthma	0.000104	0.000136	CcSEcCtD
Acamprosate—Feeling abnormal—Betamethasone—asthma	0.000104	0.000136	CcSEcCtD
Acamprosate—GABRG2—Transmembrane transport of small molecules—ADCY2—asthma	0.000104	0.00045	CbGpPWpGaD
Acamprosate—Gastrointestinal pain—Betamethasone—asthma	0.000104	0.000135	CcSEcCtD
Acamprosate—Gastrointestinal pain—Dexamethasone—asthma	0.000104	0.000135	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—IL2RA—asthma	0.000103	0.000446	CbGpPWpGaD
Acamprosate—Hypersensitivity—Triamcinolone—asthma	0.000103	0.000134	CcSEcCtD
Acamprosate—Hypersensitivity—Methylprednisolone—asthma	0.000103	0.000133	CcSEcCtD
Acamprosate—GRIN1—Axon guidance—MMP9—asthma	0.000103	0.000444	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—IL2—asthma	0.000102	0.000443	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—C3—asthma	0.000102	0.000442	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—IL6R—asthma	0.000102	0.000442	CbGpPWpGaD
Acamprosate—Diarrhoea—Hydrocortisone—asthma	0.000101	0.000132	CcSEcCtD
Acamprosate—Urticaria—Dexamethasone—asthma	0.000101	0.000131	CcSEcCtD
Acamprosate—Urticaria—Betamethasone—asthma	0.000101	0.000131	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Prednisone—asthma	0.0001	0.000131	CcSEcCtD
Acamprosate—Dizziness—Prednisolone—asthma	0.0001	0.000131	CcSEcCtD
Acamprosate—Asthenia—Triamcinolone—asthma	0.0001	0.00013	CcSEcCtD
Acamprosate—Body temperature increased—Dexamethasone—asthma	0.0001	0.00013	CcSEcCtD
Acamprosate—Abdominal pain—Dexamethasone—asthma	0.0001	0.00013	CcSEcCtD
Acamprosate—Abdominal pain—Betamethasone—asthma	0.0001	0.00013	CcSEcCtD
Acamprosate—Body temperature increased—Betamethasone—asthma	0.0001	0.00013	CcSEcCtD
Acamprosate—GRIN2B—Axon guidance—MMP9—asthma	0.0001	0.000433	CbGpPWpGaD
Acamprosate—Asthenia—Methylprednisolone—asthma	9.99e-05	0.00013	CcSEcCtD
Acamprosate—Insomnia—Prednisone—asthma	9.98e-05	0.00013	CcSEcCtD
Acamprosate—GRIN2B—Developmental Biology—IL6R—asthma	9.95e-05	0.000431	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PDGFB—asthma	9.94e-05	0.00043	CbGpPWpGaD
Acamprosate—Paraesthesia—Prednisone—asthma	9.9e-05	0.000129	CcSEcCtD
Acamprosate—Pruritus—Triamcinolone—asthma	9.88e-05	0.000128	CcSEcCtD
Acamprosate—Pruritus—Methylprednisolone—asthma	9.85e-05	0.000128	CcSEcCtD
Acamprosate—Dizziness—Hydrocortisone—asthma	9.8e-05	0.000127	CcSEcCtD
Acamprosate—Dyspepsia—Prednisone—asthma	9.71e-05	0.000126	CcSEcCtD
Acamprosate—Decreased appetite—Prednisone—asthma	9.59e-05	0.000125	CcSEcCtD
Acamprosate—Rash—Prednisolone—asthma	9.57e-05	0.000124	CcSEcCtD
Acamprosate—Dermatitis—Prednisolone—asthma	9.56e-05	0.000124	CcSEcCtD
Acamprosate—Diarrhoea—Methylprednisolone—asthma	9.53e-05	0.000124	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—LEP—asthma	9.51e-05	0.000412	CbGpPWpGaD
Acamprosate—Headache—Prednisolone—asthma	9.51e-05	0.000124	CcSEcCtD
Acamprosate—Constipation—Prednisone—asthma	9.43e-05	0.000123	CcSEcCtD
Acamprosate—Vomiting—Hydrocortisone—asthma	9.43e-05	0.000123	CcSEcCtD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—VEGFA—asthma	9.36e-05	0.000405	CbGpPWpGaD
Acamprosate—Rash—Hydrocortisone—asthma	9.35e-05	0.000122	CcSEcCtD
Acamprosate—Dermatitis—Hydrocortisone—asthma	9.34e-05	0.000121	CcSEcCtD
Acamprosate—Headache—Hydrocortisone—asthma	9.29e-05	0.000121	CcSEcCtD
Acamprosate—Dizziness—Triamcinolone—asthma	9.23e-05	0.00012	CcSEcCtD
Acamprosate—GRIN1—Developmental Biology—RHOA—asthma	9.22e-05	0.000399	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—VEGFA—asthma	9.21e-05	0.000399	CbGpPWpGaD
Acamprosate—Dizziness—Methylprednisolone—asthma	9.21e-05	0.00012	CcSEcCtD
Acamprosate—GABRA1—Transmembrane transport of small molecules—ADCY2—asthma	9.09e-05	0.000393	CbGpPWpGaD
Acamprosate—Feeling abnormal—Prednisone—asthma	9.09e-05	0.000118	CcSEcCtD
Acamprosate—Asthenia—Dexamethasone—asthma	9.09e-05	0.000118	CcSEcCtD
Acamprosate—Asthenia—Betamethasone—asthma	9.09e-05	0.000118	CcSEcCtD
Acamprosate—Gastrointestinal pain—Prednisone—asthma	9.02e-05	0.000117	CcSEcCtD
Acamprosate—Nausea—Prednisolone—asthma	9.02e-05	0.000117	CcSEcCtD
Acamprosate—GRIN2B—Developmental Biology—RHOA—asthma	8.99e-05	0.000389	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—VEGFA—asthma	8.98e-05	0.000389	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—FN1—asthma	8.97e-05	0.000388	CbGpPWpGaD
Acamprosate—Pruritus—Dexamethasone—asthma	8.96e-05	0.000117	CcSEcCtD
Acamprosate—Pruritus—Betamethasone—asthma	8.96e-05	0.000117	CcSEcCtD
Acamprosate—GABRB3—Transmembrane transport of small molecules—HMOX1—asthma	8.9e-05	0.000385	CbGpPWpGaD
Acamprosate—Vomiting—Triamcinolone—asthma	8.88e-05	0.000115	CcSEcCtD
Acamprosate—Vomiting—Methylprednisolone—asthma	8.86e-05	0.000115	CcSEcCtD
Acamprosate—Nausea—Hydrocortisone—asthma	8.81e-05	0.000115	CcSEcCtD
Acamprosate—Rash—Triamcinolone—asthma	8.8e-05	0.000114	CcSEcCtD
Acamprosate—Dermatitis—Triamcinolone—asthma	8.79e-05	0.000114	CcSEcCtD
Acamprosate—Rash—Methylprednisolone—asthma	8.78e-05	0.000114	CcSEcCtD
Acamprosate—Dermatitis—Methylprednisolone—asthma	8.77e-05	0.000114	CcSEcCtD
Acamprosate—Urticaria—Prednisone—asthma	8.76e-05	0.000114	CcSEcCtD
Acamprosate—Headache—Triamcinolone—asthma	8.74e-05	0.000114	CcSEcCtD
Acamprosate—GABRG2—Transmembrane transport of small molecules—HMOX1—asthma	8.74e-05	0.000378	CbGpPWpGaD
Acamprosate—Headache—Methylprednisolone—asthma	8.73e-05	0.000113	CcSEcCtD
Acamprosate—Body temperature increased—Prednisone—asthma	8.72e-05	0.000113	CcSEcCtD
Acamprosate—Abdominal pain—Prednisone—asthma	8.72e-05	0.000113	CcSEcCtD
Acamprosate—Diarrhoea—Dexamethasone—asthma	8.67e-05	0.000113	CcSEcCtD
Acamprosate—Diarrhoea—Betamethasone—asthma	8.67e-05	0.000113	CcSEcCtD
Acamprosate—Dizziness—Betamethasone—asthma	8.38e-05	0.000109	CcSEcCtD
Acamprosate—Dizziness—Dexamethasone—asthma	8.38e-05	0.000109	CcSEcCtD
Acamprosate—GRIN1—Axon guidance—EGFR—asthma	8.29e-05	0.000359	CbGpPWpGaD
Acamprosate—Nausea—Triamcinolone—asthma	8.29e-05	0.000108	CcSEcCtD
Acamprosate—Nausea—Methylprednisolone—asthma	8.27e-05	0.000108	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—POMC—asthma	8.17e-05	0.000354	CbGpPWpGaD
Acamprosate—Hypersensitivity—Prednisone—asthma	8.13e-05	0.000106	CcSEcCtD
Acamprosate—GRIN2B—Axon guidance—EGFR—asthma	8.08e-05	0.00035	CbGpPWpGaD
Acamprosate—Vomiting—Betamethasone—asthma	8.05e-05	0.000105	CcSEcCtD
Acamprosate—Vomiting—Dexamethasone—asthma	8.05e-05	0.000105	CcSEcCtD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—TNF—asthma	8.02e-05	0.000347	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CCL2—asthma	7.99e-05	0.000346	CbGpPWpGaD
Acamprosate—Rash—Dexamethasone—asthma	7.99e-05	0.000104	CcSEcCtD
Acamprosate—Rash—Betamethasone—asthma	7.99e-05	0.000104	CcSEcCtD
Acamprosate—Dermatitis—Betamethasone—asthma	7.98e-05	0.000104	CcSEcCtD
Acamprosate—Dermatitis—Dexamethasone—asthma	7.98e-05	0.000104	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—IL6R—asthma	7.97e-05	0.000345	CbGpPWpGaD
Acamprosate—Headache—Dexamethasone—asthma	7.93e-05	0.000103	CcSEcCtD
Acamprosate—Headache—Betamethasone—asthma	7.93e-05	0.000103	CcSEcCtD
Acamprosate—Asthenia—Prednisone—asthma	7.91e-05	0.000103	CcSEcCtD
Acamprosate—GRM5—Signaling by GPCR—EGFR—asthma	7.82e-05	0.000338	CbGpPWpGaD
Acamprosate—Pruritus—Prednisone—asthma	7.8e-05	0.000101	CcSEcCtD
Acamprosate—GABRA1—Transmembrane transport of small molecules—HMOX1—asthma	7.64e-05	0.000331	CbGpPWpGaD
Acamprosate—Diarrhoea—Prednisone—asthma	7.55e-05	9.81e-05	CcSEcCtD
Acamprosate—Nausea—Dexamethasone—asthma	7.52e-05	9.78e-05	CcSEcCtD
Acamprosate—Nausea—Betamethasone—asthma	7.52e-05	9.78e-05	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—SERPINE1—asthma	7.46e-05	0.000323	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—MMP9—asthma	7.32e-05	0.000317	CbGpPWpGaD
Acamprosate—Dizziness—Prednisone—asthma	7.29e-05	9.49e-05	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—RHOA—asthma	7.2e-05	0.000312	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—MMP9—asthma	7.14e-05	0.000309	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—NOS3—asthma	7.13e-05	0.000308	CbGpPWpGaD
Acamprosate—Vomiting—Prednisone—asthma	7.01e-05	9.12e-05	CcSEcCtD
Acamprosate—Rash—Prednisone—asthma	6.95e-05	9.04e-05	CcSEcCtD
Acamprosate—Dermatitis—Prednisone—asthma	6.95e-05	9.04e-05	CcSEcCtD
Acamprosate—Headache—Prednisone—asthma	6.91e-05	8.99e-05	CcSEcCtD
Acamprosate—GRIN1—Developmental Biology—VEGFA—asthma	6.58e-05	0.000285	CbGpPWpGaD
Acamprosate—Nausea—Prednisone—asthma	6.55e-05	8.52e-05	CcSEcCtD
Acamprosate—GRIN1—Developmental Biology—STAT3—asthma	6.51e-05	0.000282	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—IL6—asthma	6.48e-05	0.00028	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—VEGFA—asthma	6.41e-05	0.000277	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—IL6—asthma	6.37e-05	0.000276	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—STAT3—asthma	6.35e-05	0.000275	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CXCL8—asthma	6.32e-05	0.000274	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—IL6—asthma	6.21e-05	0.000269	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IL2—asthma	6.04e-05	0.000261	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—TGFB1—asthma	6.03e-05	0.000261	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—IL6—asthma	6.01e-05	0.00026	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—EGFR—asthma	5.92e-05	0.000256	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—TGFB1—asthma	5.88e-05	0.000255	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—EGFR—asthma	5.77e-05	0.00025	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MMP9—asthma	5.72e-05	0.000247	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PTEN—asthma	5.68e-05	0.000246	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—TNF—asthma	5.64e-05	0.000244	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—TNF—asthma	5.49e-05	0.000238	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—ALB—asthma	5.35e-05	0.000231	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—ALB—asthma	5.25e-05	0.000227	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—VEGFA—asthma	5.13e-05	0.000222	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—STAT3—asthma	5.08e-05	0.00022	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—TGFB1—asthma	4.71e-05	0.000204	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—EGFR—asthma	4.62e-05	0.0002	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—ALB—asthma	4.59e-05	0.000199	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—IL6—asthma	4.55e-05	0.000197	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—IL6—asthma	4.43e-05	0.000192	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IL6—asthma	3.55e-05	0.000154	CbGpPWpGaD
